Will Asundexian Change Secondary Stroke Prevention?

11 Nov 2026 0 comments

With the first factor XIa inhibitor now FDA-approved, stroke experts weigh its potential to transform secondary stroke prevention — and the challenges that could limit its adoption.
Medscape Medical News

Source: Medscape Neurology Published 11 Nov 2026 Imported 11 Nov 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment